Provista Diagnostics
New York
About Provista Diagnostics
Provista Diagnostics is a Delaware company, develops and commercializes breakthrough, easy-to-administer blood-based diagnostic tests for early oncology-related disease state recognition and detection purposes. The Company's focus is on oncology-related diagnostics where a significantly high, unmet clinical need for such testing products exists. Near-term development and commercialization efforts focus on women's cancers such as breast and ovarian cancer. Provista Diagnostic’s technologies are developed at our CLIA accredited, GLP compliant, 13,610 sq/ft laboratory facility based in Scottsdale, Arizona. Recently, Provista has formed corporate headquarters in New York to take advantage of the sales, marketing, regulatory and financial expertise in the northeast US.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $34.5M
- Funding stage: M&A
- Last round: Series Unknown (Mar 2016)
- Website: provistadx.com
- Phone: (212)202-3170
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Oncology
Social Profiles
Canonical: https://fsome.com/organization/provista-diagnostics-147343 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.